Severe Sinus Pain And Congestion Daytime

Severe Sinus Pain And Congestion Daytime

Severe Sinus Pain And Congestion Daytime Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

The introduction of additives to any solution, regardless of type of container, requires special attention to ensure that no incompatibilities result. While some incompatibilities are readily absorbed, one must be aware that subtle physical, chemical and pharmacological incompatibilities can occur. The medical literature, the package insert and other available sources of information should be reviewed for thorough understanding of possible incompatibilities.

Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema and sodium retention.

Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.

Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) should be used with great care in patients with metabolic or respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.

Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) should not be administered simultaneously with blood through the same administration set because of likelihood of coagulation.

The intravenous administration of Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, over-hydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overloading causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.

In patients with diminished renal function, administration of Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) may result in sodium or potassium retention.

Do not administer to horses by intraperitoneal injection. Do not administer to animals with inadequate renal function. Not for use in lactic acidosis.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Sykes Electrolyte Solution Compound Sodium Lactate (Hartmann’s Solution) is indicated as a source of water and electrolytes for all species. It is also used as an alkalinizing agent.

History

There is currently no drug history available for this drug.

Other Information

Sykes Electrolyte Solution Compound Sodium Lactate (Hartmanns Solution) is a sterile, non-pyrogenic solution intended for fluid and electrolyte replenishment in single dose containers. May be administered intravenously, subcutaneously or intraperitoneally (except in horses) using aseptic technique. It contains no antimicrobial agents. Discard any unused portion. Composition, osmolarity, pH and ionic concentration are shown in Table 1.

Table 1

Composition (g/L)Sodium ChloridePotassium Chloride Calcium ChlorideSodium Lactate*
 6.0 0.40 0.28 3.24
  Ionic Concentration (mEq/L)SodiumPotassium Calcium ChlorideLactate 
 131 5 2 111 29

*Sodium Lactate USP (S)-enantiomer

Osmolarity (mOsmol/L) (calc): 280mOsmol per litre

pH: 6.5 (limit 6.0 7.0)

The container is free of PVC and phthalates. It is fabricated from 5 layer polyolefin based co-extrusion material. The container meets the requirements of USP (Class VI) and is registered under US FDA DMF#9705.

Severe Sinus Pain And Congestion Daytime Manufacturers


  • Woonsocket Prescription Center,incorporated
    Severe Sinus Pain And Congestion Daytime (Acetaminophen, Guaifenesin, Phenylephrine Hcl) Tablet, Film Coated [Woonsocket Prescription Center,incorporated]

Login To Your Free Account